Hypera S.A. (HYPMY)
OTC
Closed
Sep 25, 2026
Day's Range
4.6352 wk Range
3.71Profile - HYPMY - Hypera S.A.
Profile
Mic Code
PINX
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
10.56K
Hypera S.A. is a leading Brazilian pharmaceutical company engaged in the research, development, manufacturing, and marketing of a diverse range of health-related products. Primarily, it focuses on the production of over-the-counter medications, prescription drugs, and consumer health products, serving a broad spectrum of healthcare needs. The company's product portfolio includes analgesics, antacids, vitamins, and supplements, as well as dermatological and personal care items. Hypera S.A. plays a significant role in the Brazilian and Latin American pharmaceutical landscape, leveraging its extensive distribution network to reach hospitals, pharmacies, and drugstores across the region. Its influence extends across various sectors of the healthcare industry, supported by strategic partnerships and a strong emphasis on innovation. As a major player, Hypera contributes to addressing public health challenges by fostering accessible and effective healthcare solutions. Its ongoing focus on research and development allows it to adapt and respond to dynamic market demands, reinforcing its commitment to improving the quality of life for consumers throughout its markets.
Profile Details
Type
American Depositary Receipt
Address
Av. Magalhães de Castro, 4800
City
São Paulo
State
SP
Zip
05676-120
Country
Brazil
Phone
55 11 3627 4206
Key Executives - HYPMY - Hypera S.A.
Key executives
Cross Listings - HYPMY - Hypera S.A.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
